RecruitingPhase 4NCT06236022

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Studying Dilated cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tongji Hospital
Principal Investigator
Dao Wen Wang, Doctor
Tongji Hospital
Intervention
Sirolimus(drug)
Enrollment
276 enrolled
Eligibility
18-70 years · All sexes
Timeline
20242028

Study locations (1)

Collaborators

Wuhan Central Hospital · Wuhan Fourth Hospital · Wuhan University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06236022 on ClinicalTrials.gov

Other trials for Dilated cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Dilated cardiomyopathy

← Back to all trials